Chiome Bioscience Inc.
4583.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥8,981 | ¥10,121 | ¥9,799 | ¥17,163 |
| - Cash | ¥1,006 | ¥1,475 | ¥1,819 | ¥2,063 |
| + Debt | ¥79 | ¥261 | ¥282 | ¥282 |
| Enterprise Value | ¥8,055 | ¥8,907 | ¥8,262 | ¥15,381 |
| Revenue | ¥118 | ¥113 | ¥139 | ¥358 |
| % Growth | 4.4% | -18.5% | -61.3% | – |
| Gross Profit | ¥65 | ¥58 | ¥81 | ¥213 |
| % Margin | 55.3% | 51.5% | 58.1% | 59.5% |
| EBITDA | -¥257 | -¥272 | -¥264 | -¥110 |
| % Margin | -217.7% | -240.8% | -190.6% | -30.6% |
| Net Income | -¥260 | -¥274 | -¥266 | -¥105 |
| % Margin | -220.3% | -242.5% | -191.8% | -29.4% |
| EPS Diluted | -3.82 | -4.04 | -3.94 | -1.65 |
| % Growth | 5.4% | -2.5% | -138.8% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |